FindTrial
Sign In

To evaluate the efficacy of Qurse Ziabetes.

An open intervention trial of Qurse Ziabetes ( A formulation of Sabith bin Qurrah) in the secondary prevention of Ziabetes shakri (Diabetes mellitus type-2)

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/02/031597
Enrollment
40
Registered
2021-02-26
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E119- Type 2 diabetes mellitus without complications

Interventions

Intervention1: Qurs Ziabetes: All the dried ingredients are grinded into powdered form and mixed with Luab-e-Asapgoal will be given 7 masha orally Control Intervention1: Not Applicable: Not Applicable

Sponsors

National Institute of Unani Medicine
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patient between 35-60 years of age Patients of both genders Fasting blood sugar >=126 - Post prandial blood sugar >=200 -

Exclusion criteria

Exclusion criteria: Patient less than 35 & above 60 years of age Fasting blood sugar >=200 Post prandial blood sugar >=300 Pregnant and lactating women Patient with history of any systemic illnesses Patients who are on medication > 3hypoglycaemic drugs Patients with any known Cardiovascular disease.

Design outcomes

Primary

MeasureTime frame
Improvement in the objective parametersTimepoint: 60 days—

Secondary

MeasureTime frame
Improvement in subjective parametrsTimepoint: 60 days—

Countries

India

Contacts

Public ContactProf AMKSherani

National Institute of Unani Medicine

arish_sherwani@yahoo.co.in9448794691

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026